Nerve growth factor modulation of the cavernous nerve response to injury

Journal of Sexual Medicine

Volumn 6, Issue SUPPL. 3, 2009, Pages 347-352

  Bella, Anthony J ^a,b,d   Lin, Guiting ^c   Lin, Ching Shwun ^b   Hickling, Duane R ^b   Morash, Christopher ^b   Lue, Tom F ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Animal model; BDNF; Erectile dysfunction; GDF 5; Nerve growth factors; Neurogenic impotence; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GROWTH DIFFERENTIATION FACTOR 5; NERVE GROWTH FACTOR; NEURTURIN;

CAVERNOUS NERVE INJURY; CONFERENCE PAPER; DRUG TARGETING; ERECTILE DYSFUNCTION; HUMAN; NERVE REGENERATION; NEUROBIOLOGY; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 61849142125     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.01194.x     Document Type: Conference Paper

References (48)

1. Wang R. Penile rehabilitation after radical prostatectomy: Where do we stand and where are we going? J Sex Med 2007; 4: 1085-97.
2. Nelson CJ, Choi JM, Mulhall JP, Roth AJ. Determinants of sexual satisfaction in men with prostate cancer. J Sex Med 2007; 4: 1422-7.
3. Walsh PC. Anatomic radical prostatectomy: Evolution of the surgical technique. J Urol 1998; 160: 2418-24.
4. Bella AJ, Lin GT, Cagiannos I, Lue TF. Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury. Asian J Androl 2008; 10: 54-60.
5. Burnett AL. Neuroprotection and potential for ED in radical prostatectomy. J Sex Med 2007; 4: 34.
6. Miles C, Candy B, Jones L, Williams R, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst Rev 2007; 4: CD005540.
7. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532-40.
8. Mulhall JP, Morgentaler A. Penile rehabilitation should become the norm for radical prostatectomy patients. J Sex Med 2007; 4: 538-43.
9. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007; 178: 597-601.
10. Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, Studer UE. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172: 1323-7.
11. Keating JP. Sexual function after rectal excision. ANZ J Surg 2004; 74: 248-59.
12. Lin G, Bella AJ, Lue T, Lin CS. Brain-derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: Part 2. J Sex Med 2006; 3: 821-9.
13. Nangle MR, Keast JR. Reduced efficacy of nitrergic neurotransmission exacerbates erectile dysfunction after penile nerve injury despite axonal regeneration. Exp Neurol 2007; 207: 30-41.
14. Podlasek CA, Meroz CL, Tang Y, McKenna KE, McVary KT. Regulation of cavernous nerve injury-induced apoptosis by sonic hedgehog. Biol Reprod 2007; 76: 19-28.
15. Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med 2008; 5: 1776-85.
16. Bella AJ, Lin G, Tantiwongse K, Garcia M, Lin CS, Brant W, Lue TF. Brain-derived neurotrophic factor (BDNF) acts primarily via the JAK/STAT pathway to promote neurite growth in the major pelvic ganglion of the rat: Part 1. J Sex Med 2006; 3: 815-20.
17. Ng BK, Chen L, Mandemakers W, Cosgaya JM, Chan JR. Anterograde transport and secretion of brain-derived neurotrophic factor along sensory axons promote Schwann cell myelination. J Neurosci 2007; 27: 7597-603.
18. Burnett AL, Lue TF. Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery. J Urol 2006; 176: 882-87.
19. Mehta N, Sikka S, Rajasekaran M. Rat as an animal model for male erectile function evaluation in sexual medicine research. J Sex Med 2008; 5: 1278-83.
20. Hsieh PS, Bochinski DJ, Lin GT, Nunes L, Lin C-S, Lue TF. The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int 2003; 92: 470-5.
21. Chen KC, Minor TX, Rahman NU, Ho HC, Nunes L, Lue TF. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model or neurogenic impotence. BJU Int 2005; 95: 1077-80.
22. Bakircioglu ME, Lin C-S, Fan P, Sievert KD, Kan WY, Lue TF. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol 2001; 165: 2103-9.
23. Mitsui T, Fischer I, Shumsky JS, Murray M. Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats. Exp Neurol 2005; 194: 410-31.
24. Bella AJ, Lin G, Garcia MM, Tantiwonge T, Lin CS, Brant WO, Lue TF. Upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signaling pathway in the major pelvic ganglion of the rat following cavernous nerve transection. Eur Urol 2007; 52: 574-81.
25. Hiltunen JO, Laurikainen A, Klinge E, Saarma M. Neurotrophin-3 is a target derived neurotrophic factor for penile erection-inducing neurons. Neuroscience 2005; 133: 51-8.
26. Lin G, Chen KC, Hsieh PS, Yeh CH, Lue TF, Lin C-S. Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured pelvic ganglia. BJU Int 2003; 92: 631-5.
27. Michel MC. Editoral comment upregulation of penile brain-derived neurotrophic factor (BDNF) and activation of the JAK/STAT signaling pathway in the major pelvic ganglion of the rat following cavernous nerve transection. Eur Urol 2007; 52: 580-1.
28. Bella AJ, Lin G, Tantiwongse K, Banie L, Brant WO, Lue TF. Age-related decrease for in vivo brain-derived neurotrophic growth factor (BDNF) expression in response to cavernous nerve axotomy: A neuromodulatory target for enhancing nerve recovery. J Urol 2008; 179 (4 suppl): 232 [abstract 661].
29. Bella AJ. Molecular Mechanisms of Cavernous Nerve Regeneration [presentation]. Society for Basic Urologic Research Forum at the American Urological Association Annual Meeting, Orlando, FL, May 2008.
30. Bella AJ, Lin G, Banie L, Tantiwongse K, Brant WO, Lue TF. In vivo brain derived neurotrophic expression and timing patterns in aged rats following cavernous nerve axotomy. CUAJ 2007; 1: 157 [abstract 2.01].
31. Hötten G, Neidhardt H, Jacobowsky B, Pohl J. Cloning and expression of recombinant human growth/differentiation factor 5. Biochem Biophys Res Commun 1994; 204: 646-52.
32. Sullivan AM, O'Keeffe GW. The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurons: Relevance to Parkinson's disease treatment. J Anat 2005; 207: 219-26.
33. Krieglstein K, Suter-Crazzolara C, Hötten G, Pohl J, Unsicker K. Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons. J Neurosci Res 1995; 42: 724-32.
34. Schreuder H, Liesum A, Pohl J, Kruse M, Koyama M. Crystal structure of recombinant human growth and differentiation factor 5: Evidence for interaction of the type I and type II receptor-binding sites. Biochem Biophys Res Commun 2005; 329: 1076-86.
35. Chen X, Zankl A, Niroomand F, Liu Z, Katus HA, Jahn L, Tiefenbacher C. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol 2006; 41: 26-33.
36. Magit DP, Maak T, Trioano N, Raphael B, Hamouria Q, Polzhofer G, Drespe I, Albert TJ, Grauer JN. Healos/recombinant human growth and differentiation factor-5 induces posterolateral lumbar fusion in a New Zealand white rabbit model. Spine 2006; 31: 2180-8.
37. Farkas LM, Scheuermann S, Pohl J, Unsicker K, Krieglstein K. Characterization of growth/differentiation factor 5 (GDF-5) as a neurotrophic factor for cultured neurons from chicken dorsal root ganglia. Neurosci Lett 1997; 236: 120-2.
38. Niere M, Braun B, Gass R, Sturany S, Volkmer H. Combination of engineered neural cell adhesion molecules and GDF-5 for improved neurite extension in nerve guide concepts. Biomaterials 2006; 27: 3432-40.
39. Fandel T, Bella AJ, Tantiwongse K, Garcia M, Nunes L, Thuroff JW, Tanagho EA, Lue TF. The effect of intracavernous growth differentiation factor-5 in a rat model of cavernous nerve injury. BJU Int 2006; 98: 632-36.
40. Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin C-S, Pohl J, Lue TF. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury. J Sex Med 2008; 5: 1866-75.
41. Laurikainen A, Hiltunen JO, Vanhatalo S, Klinge E, Saarma M. Glial cell line-derived neurotrophic factor is expressed in the penis of adult rat and retrogradely transported in penile parasympathetic and sensory nerves. Cell Tissue Res 2000; 302: 321-9.
42. Laurikainen A, Hiltunen JO, Thomas-Crusells J, Vanhatalo S, Arumae U, Airaksinen MS, Klinge E, Saarma M. Neurturin is a neurotrophic factor for penile parasympathetic neurons in adult rat. J Neurobiol 2000; 43: 198-205.
43. Palna CA, Keast JR. Structural effects and potential changes in growth factor signaling in penis-projecting autonomic neurons after axotomy. BMC Neuroscience 2006; 7: 41.
44. Sanicola M, Hession CA, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, Whitty A, Pepinsky RB, Cate RL. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad U S A 1997; 94: 6238-43.
45. Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olsen L. Neurturin and glial cell line-derived neurotrophic factor receptor-β (GDNFR-β), novel proteins related to GDNF and GDNFR-α with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci 1997; 17: 8506-19.
46. Wanigasekara Y, Keast JR. Neurturin has multiple neurotrophic effects on adult sacral parasympathetic ganglion neurons. Eur J Neurosci 2005; 25: 595-604.
47. Bella AJ, Fandel TM, Tantiwongse K, Brant WO, Klein R, Garcia CA, Lue TF. Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat. J Brachial Plex Peripher Nerve Inj 2007; 2: 5.
48. Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, Krisky DM, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Ther 2007; 14: 1344-52.